Home Online Features Revance Stockholders Urged to Tender Their Shares in Support of Crown Transaction by the February 4th Deadline
Revance Stockholders Urged to Tender Their Shares in Support of Crown Transaction by the February 4th Deadline
Press Releases
February 1, 2025

Revance Stockholders Urged to Tender Their Shares in Support of Crown Transaction by the February 4th Deadline

By Crown Laboratories, Inc., Revance Therapeutics, Inc.

Crown offer of $3.65 per share is the only offer available to Revance stockholdersCrown offer unanimously approved by the Revance Board of DirectorsTeoxane withdraws its previous proposal, says it will

bradford

The Bradford Era

email
Local & Social